Skip to content
Ranked #166
Medro

Compounded or brand semaglutide/tirzepatide with transparent tiered pricing and no membership, all 50 states.

semaglutide
$199/mo
tirzepatide
$299/mo
Before enrolling

Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.

vs
Ranked #18Desk pick
Pallas Health

Readers who weight named pharmacies and independently verifiable prescribers above cash-flow flexibility, and who can absorb a $597 or $897 charge every twelve weeks rather than a monthly one.

semaglutide
$199/mosee conditions
tirzepatide
$299/mosee conditions
Before enrolling

There is no month-to-month rung for either compounded molecule — the funnel renders no cadence selector — so the advertised “$199/mo average” is a single $597 charge every twelve weeks divided by three

Our review of Pallas Health gives it 87/100 (B+), while our review of Medro gives it 71/100 (C). The score breakdown shows where each provider does better.

Desk Score, dimension by dimension

Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.

Medro

71/100

C

Overall

Pallas Health

87/100

B+

Price transparency

52
78

State access

86
94

Molecule range

79
90

Onboarding speed

78
88

Support responsiveness

64
88

Licensing & trust

70
90

The spec sheet

Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.

FieldMedroPallas Health
Semaglutide$199/mo
Full plan terms

$199/mo (compounded)

$199/mosee conditions
Full plan terms

$199/mo average (compounded injectable; $597 billed every 12 weeks after $139 for the first 4 weeks; no month-to-month tier is sold)

Tirzepatide$299/mo
Full plan terms

$299/mo (compounded)

$299/mosee conditions
Full plan terms

$299/mo average (compounded injectable; $897 billed every 12 weeks after $179 for the first 4 weeks; no month-to-month tier is sold)

CoverageAll 50 statesAll 50 states + DC (async in 43; 7 states plus DC require one video visit)
Brand-nameBrand-name option listedBrand-name option listed
Oral optionNot confirmed hereNot confirmed here
Best forCompounded or brand semaglutide/tirzepatide with transparent tiered pricing and no membership, all 50 states.Readers who weight named pharmacies and independently verifiable prescribers above cash-flow flexibility, and who can absorb a $597 or $897 charge every twelve weeks rather than a monthly one.
Desk Score71/100C87/100B+

The verdict

Desk pick — Pallas Health

Pallas Health has the higher Desk Score, but Medro may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.

Choose Medro if…

Compounded or brand semaglutide/tirzepatide with transparent tiered pricing and no membership, all 50 states.

$199/mo sema · $299/mo tirz · All 50 states

Choose Pallas Health if…

Readers who weight named pharmacies and independently verifiable prescribers above cash-flow flexibility, and who can absorb a $597 or $897 charge every twelve weeks rather than a monthly one.

$199/mo (see conditions) sema · $299/mo (see conditions) tirz · All 50 states + DC (async in 43; 7 states plus DC require one video visit)

Assume any provider we list may compensate us. We may earn a referral commission at no extra cost to you, and compensation does not change the Desk Score.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.